EBM Flashcards

1
Q

Hierarchy of study design

A
Systematic reviews & meta-analyses 
Randomised Controlled Trials
Cohort studies 
Case-control studies
Ecological studies
Descriptive/cross-sectional studies
Case report/series
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Evidence Based Medicine

A

conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Role of EBM in clinical medicine

A
Clinical findings
Aetiology
Clinical manifestations of disease
Differential diagnosis
Diagnostic tests
Prognosis
Therapy
Prevention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Criticism of EBM

A

Time consuming

Jargon is used inappropriately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why EBM matters to clinicians

A
Better service for patients
Patient care + safety
Medical knowledge
Revalidation
Professionalism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Systemic reviews + meta analysis

A

Aims to answer defined research question by collecting & summarising empirical evidence that fits pre-specified eligibility criteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Advantages to systemic approach

A

Transparent inclusion of studies
MA increases power of study
May identify lack of adequate evidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Randomised Control Trial

A

Selection for people you want to experiment on.

GOLD STANDARD for clinical trials & surgical interventions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

RCT disadvantages

A

–With some treatment, effect might be weak so trials may need to be very large to demonstrate an effect.
–Expensive!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cohort

A

Individuals selected on basis of exposure status &
followed over time to allow frequency of occurrence of outcome of interest in exposed & non-exposed groups to be compared.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Time period of cohort

A

Prospective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What can be calculated from cohort studies

A

Relative risk
Incidence
Which came 1st incidence or risk factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Advantages of cohort studies

A

looks at multiple outcomes
follows natural history of disease
minimise bias in estimating exposure as prospective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Disadvantages of cohort studies

A

Inefficient for rare diseases
Expensive
Time consuming
Loss of follow-up =Bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Case control studies

A

Selection based on whether or not they have outcome of interest
Exposure (risk factor) status explored to establish whether exposure is more common in the case or control group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Case control studies determine

A

whether an exposure is associated with an outcome

17
Q

What can be calculated from a case control study

A

Odds ratio

18
Q

Advantages of case control study

A

Quick
Cheap
Good for outbreaks of infectious/ rare disease
Can investigate many exposures simultaneously

19
Q

Disadvantages of case control study

A
Problems of selection of controls
Subject to recall bias
Uncertainty of exposure-disease time relationship
Poor for rare exposures
Can't calculate incidence directly
20
Q

Case control study time period

A

Retrospective

21
Q

Ecological studies

A

Type of descriptive study

Uses correlations between different populations, using different exposures

22
Q

Descriptive/ cross-sectional studies

A

Based on routinely collected data. Difficult to show causal relationship

23
Q

Descriptive/ cross-sectional study example

A

Survey

Census

24
Q

Case report/ series

A

–Description of single case/ series of cases.

–NOT evidence used to support practice BUT sometimes useful in picking out new syndromes or conditions.

25
Q

Reporting guidelines for RCT

A

CONSORT

26
Q

Reporting guidelines for observational studies

A

STROBE

27
Q

Reporting guidelines for systematic reviews

A

PRISMA/MOOSE